Matthew Jenusaitis is Director of enVVeno Medical Corp. Currently has a direct ownership of 16,545 shares of NVNO, which is worth approximately $53,109. The most recent transaction as insider was on Dec 19, 2024, when has been sold 9,620 shares (Common Stock) at a price of $2.53 per share, resulting in proceeds of $24,338. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16.5K
138.92% 3M change
138.92% 12M change
Total Value Held $53,109

Matthew Jenusaitis Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 19 2024
BUY
Open market or private purchase
$24,338 $2.53 p/Share
9,620 Added 36.77%
16,545 Common Stock
Sep 13 2022
BUY
Exercise of conversion of derivative security
-
1,041 Added 13.07%
6,925 Common Stock
Sep 13 2021
BUY
Exercise of conversion of derivative security
-
1,042 Added 15.04%
5,884 Common Stock
Aug 25 2021
BUY
Open market or private purchase
$10,010 $7.7 p/Share
1,300 Added 21.17%
4,842 Common Stock, $$0.0000...
Jul 18 2020
BUY
Grant, award, or other acquisition
-
62,500 Added 50.0%
62,500 Common Stock
MJ

Matthew Jenusaitis

Director
Irvine, CA

Track Institutional and Insider Activities on NVNO

Follow enVVeno Medical Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NVNO shares.

Notify only if

Insider Trading

Get notified when an En V Veno Medical Corp insider buys or sells NVNO shares.

Notify only if

News

Receive news related to enVVeno Medical Corp

Track Activities on NVNO